Policy | September 11, 2023
G20 New Delhi Leaders' Declaration on strengthening global health
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
SKYSCRAPER-01 is ongoing and the study remains blinded to patients and investigators
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
Oteseconazole Capsules were found to be safe and more effective than fluconazole
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
